Genomics for disease treatment and prevention.

  title={Genomics for disease treatment and prevention.},
  author={Cinnamon S. Bloss and Dilip V. Jeste and Nicholas J. Schork},
  journal={The Psychiatric clinics of North America},
  volume={34 1},

Tables from this paper

Genomics Education in the Era of Personal Genomics: Academic, Professional, and Public Considerations

The influence of personal genomics in society is discussed and the importance and benefits of genomics education in the classroom, clinics, and the public are focused on and the potential consequences of personal genomic education are explored.

Genomics and Genetic Testing

  • Biology
    Examining the Causal Relationship Between Genes, Epigenetics, and Human Health
  • 2019
This chapter focuses on the Human Genome Project (HGP), which determined that humans have between 20,000 to 25,000 protein-coding genes and only about 1.5% of the genome codes for proteins, rRNA, and

Assessing the Costs and Cost-Effectiveness of Genomic Sequencing

Attempts in the MedSeq Project are described, to understand the costs and cost-effectiveness of integrating whole genome sequencing into cardiology and primary care settings, and the implications for secondary findings disclosure and the integration of genomes into general patient care.

Development of a Communication Protocol for Telephone Disclosure of Genetic Test Results for Cancer Predisposition

A theoretically grounded and rigorously developed protocol for telephone communication of BRCA1/2 (breast cancer) test results that might be generalizable to genetic testing for other hereditary cancer and noncancer syndromes is developed.

Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges

To fully realize the benefits of PM for healthcare systems and patients, regulatory, intellectual property, and reimbursement challenges need to be addressed in lock step with scientific advances.

Direct-to-consumer personalized genomic testing.

DTC genomic testing for common markers and conditions is only a precursor to the eventual cost-effectiveness and wide availability of whole genome sequencing of individuals, although it remains unclear whether DTC genomic information will still be attainable.

Four Actionable Bottlenecks and Potential Solutions to Translating Psychiatric Genetics Research: An Expert Review

Researchers are urged to consider how their research is translational in the context of the frameworks, genetic information, and psychiatric disorders discussed in this review to help improve and increase translation in the field of psychiatric genetics.

A systematic review of the factors associated with interest in predictive genetic testing for obesity, type II diabetes and heart disease.

  • J. CollinsL. RyanH. Truby
  • Medicine
    Journal of human nutrition and dietetics : the official journal of the British Dietetic Association
  • 2014
Interest in predictive genetic testing for obesity, type II diabetes or heart disease was greatest amongst those who perceived the risk of disease to be high and/or the outcomes of testing to be beneficial.

The importance of gene-environment interactions in human obesity.

A growing body of evidence has provided a deeper understanding of GEI influencing obesity and may have tremendous applications in the emerging field of personalized medicine and individualized lifestyle recommendations.



Genomic and personalized medicine: foundations and applications.

  • G. GinsburgH. Willard
  • Medicine
    Translational research : the journal of laboratory and clinical medicine
  • 2009

From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.

Se sequencing of the entire human genome, the mapping of common haplotypes of single-nucleotide polymorphisms (SNPs), and cost-effective genotyping technologies leading to genome-wide association studies - have combined convincingly in the past several years to demonstrate the requirements needed to separate true associations from the plethora of false positives.

The HapMap and genome-wide association studies in diagnosis and therapy.

The development and application of the HapMap to genome-wide association (GWA) studies; present and future technologies for GWA research; current major efforts in GWA studies; successes and limitations of the GWA approach in identifying polymorphisms related to complex diseases; data release and privacy polices; and sources of ongoing authoritative information on this rapidly evolving field are examined.

DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.

Four major areas that need to be addressed collectively to assure that pharmacogenomics continues to mature over the next 10 years into a science that is essential to the practice of medicine are presented.

Future health applications of genomics: priorities for communication, behavioral, and social sciences research.

Prediction of individual genetic risk of complex disease.

The role of companion diagnostics in the development and use of mutation-targeted cancer therapies

Development of companion diagnostic tests for this identification of patients most likely to benefit from therapies based on agents that specifically target the products of the genes that are mutated in cancer cells is proceeding.

A HapMap harvest of insights into the genetics of common disease.

HapMap-based discoveries have shed new light on the impact of evolutionary pressures on the human genome, suggesting multiple loci important for adapting to disease-causing pathogens and new environments.

The implications of gene–environment interactions in depression: will cause inform cure?

  • R. Uher
  • Psychology, Biology
    Molecular Psychiatry
  • 2008
A model of depression is proposed that incorporates the interacting genetic and environmental factors over the life course and provides an explanatory framework for the heterogeneous aetiology of depression.

Finding the missing heritability of complex diseases

Genome-wide association studies have identified hundreds of genetic variants associated with complex human diseases and traits, and have provided valuable insights into their genetic architecture.